Clinical trial
Evaluation of Mer and Axl Expression in Acute Myeloid Leukemia Patient Samples
NCT01139333 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Mer and Axl Expression in Acute Myeloid Leukemia Patient Samples
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- Not reported
- Enrollment
- 52 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.